Conrad, M. ; Lorenz, S. & Proneth, B. Targeting ferroptosis: New hope for as-yet-incurable diseases. Trends Mol. Med. 27, 113-122 (2021)
Kobold, S. An in sitro assay to predict primary resistance to PD-1 blockade. Trends Mol. Med. 27, 297-298 (2021)
Bocchi, R. & Götz, M. Neuronal reprogramming for brain repair: Challenges and perspectives. Trends Mol. Med. 26, 890-892 (2020)
Neumeyer; S. ; Hemani, G.* & Zeggini, E. Strengthening causal inference for complex disease using molecular quantitative trait loci. Trends Mol. Med. 26, 232-241 (2020)
Fujita, Y.* ; Tinoco, R.* ; Li, Y.* ; Senft, D. & Ronai, Z.A.* Ubiquitin ligases in cancer immunotherapy - balancing antitumor and autoimmunity. Trends Mol. Med. 25, 428-443 (2019)
Finan, B. ; Müller, T.D. ; Clemmensen, C. ; Perez-Tilve, D.* & Tschöp, M.H. Reappraisal of GIP pharmacology for metabolic diseases. Trends Mol. Med. 22, 359-376 (2016)
Ovsepian, S.V. ; O'Leary, V.B. ; Ntziachristos, V. & Dolly, J.O.* Circumventing brain barriers: Nanovehicles for retroaxonal therapeutic delivery. Trends Mol. Med. 22, 983-993 (2016)
Griciuc, A. ; Aron, L.* & Ueffing, M. ER stress in retinal degeneration: A target for rational therapy? Trends Mol. Med. 17, 442-451 (2011)
Jagasia, R. ; Song, H.* ; Gage, F.H.* & Lie, D.C. New regulators in adult neurogenesis and their potential role for repair. Trends Mol. Med. 12, 400-405 (2006)
Hammerschmidt, W. & Sugden, B.* Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends Mol. Med. 10, 331-336 (2004)
Müller, M.B.* & Wurst, W. Getting closer to affective disorders: The role of CRH receptor systems. Trends Mol. Med. 10, 409-415 (2004)